rs10498635

This is a intron variant variant in the RIN3 gene.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

myeloid leukocyte count

Allele T
OR 0.03
p 7.0e-39
N 562,243
Large GWAS
European

neutrophil count

Allele T
OR 0.03
p 9.0e-34
N 519,288
Large GWAS
European

breast cancer, ovarian carcinoma

Allele C
OR
p 9.0e-13
N 295,401
Meta-analysisLarge GWAS

breast cancer, lung cancer

Allele C
OR
p 5.0e-12
N 256,160
Meta-analysisLarge GWAS

osteitis deformans

Allele C
OR 1.44
p 3.0e-11
N 3,440
Large GWAS
European

pulse pressure measurement

Allele T
OR 0.13
p 3.0e-9
N 1,028,980
Large GWAS
multi-ancestry
Allele T
OR 0.13
p 3.0e-8
N 810,865
Meta-analysisLarge GWAS
European

Research that mentions this SNP (1)

Identification of rare genetic variants in novel loci associated with Paget’s disease of bone
AssociationN=537Mariejka Beauregard et al.(2014)· Human Genetics

This association study identified 126 rare genetic variants in candidate genes within five novel Paget's disease of bone (PDB)-associated loci in a French-Canadian population (240 cases, 297 controls). The study replicated associations with common variants rs484959, rs499345, rs10494112 (1p13 locus) and rs5742915 (15q24 locus). Two rare variants showed marginal association with PDB: rs62620995 (p.Leu397Phe in TM7SF4, p=0.09, RR=2.06) and rs35500845 (c.372+259a>G in CTHRC1, p=0.046, RR=0.65).

Traits studied:Paget's disease of bone

About RIN3

Summary: This protein encoded by this gene is a member of the RIN family of Ras interaction-interference proteins, which are binding partners to the RAB5 small GTPases. The protein functions as a guanine nucleotide exchange for RAB5B and RAB31. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

View all RIN3 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…